Cases & Deals

  • Home
  • Practices
  • City of Hope licenses its unique gene editing technology to Homology Medicines Inc.

Share

City of Hope licenses its unique gene editing technology to Homology Medicines Inc.

2016

Client(s) City of Hope

Jones Day advised City of Hope in connection with an exclusive, worldwide license of its pioneering AAV-based gene editing technology to Homology Medicines Inc., a newly-formed genetic medicines company. A City of Hope lab developed the single platform technology that enables both gene editing and gene therapy with a built-in in vivo delivery system. The foundation technology is a novel non-nuclease based gene editing platform that is initially being developed to help find cures for rare genetic diseases.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.